“…Some of these compounds exhibit spasmolytic, diuretic, anticoagulant, anticancer, andantianaphylactic activity [28].Moreover they can be used as cognitive enhancers, for the handling of neurodegenerative diseases, including amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, AIDS associated dementia and Down's syndrome as well as for the treatment of schizophrenia and myoclonus [29].Despite their importance from pharmacological, industrial and synthetic point of views, comparatively few methods for the preparation of dihydropyrano[3,2-c]chromenederivatives have been reported [30].Some of the reported procedures require long reaction times; afford products with only modest yields and non-reusability of the catalyst. The use of support allows the heteropolyacids to be dispersed over a large surface area and increases their catalytic activity [33].In previous work[34], we introduce a simple, repaid, inexpensiveand one step method, solvothermal, for synthesis ofH 3 PMo 12 O 4 nanoparticles (PMA n ) from H 3 PMo 12 O 4 bulk particles (PMA b ). In recent years, brønsted acids such as Keggin-type heteropolyacids(HPAs) have been used as efficient catalysts for a variety of organic reactions because of their redox properties and superacidic, high thermal stability, ease of handling, high proton mobility, stronger acids than homogeneous acid catalysts, low toxicity, development of clean technologies and low cost [31].Although HPAs are versatile compounds intheir acidic form, their main disadvantages are high solubility inpolar solvents and low surface area (<10 m 2 /g).…”